Department of Clinical Science, University of Bergen, Bergen, Norway.
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2041-8. doi: 10.1161/ATVBAHA.113.301714. Epub 2013 May 30.
Dimethylglycine is linked to lipid metabolism, and increased plasma levels may be associated with adverse prognosis in patients with coronary artery disease. We evaluated the relationship between plasma dimethylglycine and risk of incident acute myocardial infarction in a large prospective cohort of patients with stable angina pectoris, of whom approximately two thirds were participants in a B-vitamin intervention trial. Model discrimination and reclassification when adding plasma dimethylglycine to established risk factors were obtained. We also explored temporal changes and the test-retest reliability of plasma dimethylglycine.
Four thousand one hundred fifty patients (72% men; median age 62 years) were included. Plasma dimethylglycine was associated with several traditional coronary artery disease risk factors. During a median follow-up of 4.6 years, 343 (8.3%) patients experienced an acute myocardial infarction. The hazard ratio (95% confidence interval) for acute myocardial infarction was 1.95 (1.42-2.68; P<0.001) when comparing plasma dimethylglycine quartile 4 to 1 in a Cox regression model adjusted for age, sex, and fasting status. Adjusting for traditional coronary artery disease risk factors only slightly modified the estimates, which were particularly strong among nonsmokers and among patients with serum triglyceride or apolipoprotein B100 levels ≤ median (P for interaction=0.004, 0.004, and 0.03, respectively). Plasma dimethylglycine improved discrimination and reclassification and had high test-retest reliability.
Plasma dimethylglycine is independently related to incident acute myocardial infarction and enhances risk prediction in patients with stable angina pectoris. Our results motivate further studies on the relationship between 1-carbon metabolism and atherothrombosis. A potential interplay with lipid and energy metabolism merits particular attention.
二甲氨基乙醇与脂质代谢有关,血浆水平升高可能与冠心病患者的不良预后相关。我们评估了在一个大型稳定型心绞痛患者前瞻性队列中,血浆二甲氨基乙醇与新发急性心肌梗死风险之间的关系,其中约三分之二的患者参与了维生素 B 干预试验。获得了加入现有危险因素后模型区分度和再分类的情况。我们还探讨了血浆二甲氨基乙醇的时间变化和测试-重测可靠性。
纳入了 4150 例患者(72%为男性;中位年龄 62 岁)。血浆二甲氨基乙醇与多种传统冠心病危险因素相关。在中位随访 4.6 年期间,343 例(8.3%)患者发生急性心肌梗死。在 Cox 回归模型中,将血浆二甲氨基乙醇四分位 4 与 1 进行比较,调整年龄、性别和空腹状态后,急性心肌梗死的风险比(95%置信区间)为 1.95(1.42-2.68;P<0.001)。仅调整传统冠心病危险因素略微改变了估计值,在不吸烟者和血清三酰甘油或载脂蛋白 B100 水平≤中位数的患者中,这些估计值尤其强烈(P 交互值分别为 0.004、0.004 和 0.03)。血浆二甲氨基乙醇改善了区分度和再分类,且测试-重测可靠性高。
血浆二甲氨基乙醇与新发急性心肌梗死独立相关,并增强了稳定型心绞痛患者的风险预测。我们的结果促使进一步研究 1 碳代谢与动脉粥样血栓形成之间的关系。与脂质和能量代谢之间的潜在相互作用值得特别关注。